Main menu button

News

Equity research Immunovia: PancreaSure launch in the US is underway
26 Sep 2025
Equity research Immunovia: PancreaSure launch in the US is underway
Equity Research Immunovia
Equity research Immunovia: Eventful Q2 and rights issue to support PancreaSure launch
28 Aug 2025
Equity research Immunovia: Eventful Q2 and rights issue to support PancreaSure launch
Equity Research Immunovia
Equity research Immunovia: PancreaSure test achieves CPT code assignment
02 Jul 2025
Equity research Immunovia: PancreaSure test achieves CPT code assignment
Equity Research Immunovia
Equity research Immunovia: New study and FDA choose not to appeal LDT ruling
04 Jun 2025
Equity research Immunovia: New study and FDA choose not to appeal LDT ruling
Equity Research Immunovia
Equity research Immunovia: All eyes on securing the launch of PancreaSure
15 Mai 2025
Equity research Immunovia: All eyes on securing the launch of PancreaSure
Equity Research Immunovia
Equity Research Immunovia: Regulatory tailwind in the USA following ruling against the FDA
01 Apr 2025
Equity Research Immunovia: Regulatory tailwind in the USA following ruling against the FDA
Equity Research Immunovia
Equity Research Immunovia: Second clinical validation of next-generation test
19 Mrz 2025
Equity Research Immunovia: Second clinical validation of next-generation test
Equity Research Immunovia
Equity Research Immunovia: Making headway with new cancer screening test
26 Feb 2025
Equity Research Immunovia: Making headway with new cancer screening test
Equity Research Immunovia
Investment Case Immunovia: Promising clinical data and incoming triggers
11 Dez 2024
Investment Case Immunovia: Promising clinical data and incoming triggers
Equity Research Immunovia